BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21908737)

  • 21. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo.
    Martin B; Banz A; Bienvenu B; Cordier C; Dautigny N; Bécourt C; Lucas B
    J Immunol; 2004 Mar; 172(6):3391-8. PubMed ID: 15004137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endotoxin hyperresponsiveness upon CD4+ T cell reconstitution in lymphopenic mice: control by natural regulatory T cells.
    De Wilde V; Benghiat FS; Novalrivas M; Lebrun JF; Kubjak C; Oldenhove G; Verdebout JM; Goldman M; Le Moine A
    Eur J Immunol; 2008 Jan; 38(1):48-53. PubMed ID: 18085667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells.
    Tobiasova Z; Zhang L; Yi T; Qin L; Manes TD; Kulkarni S; Lorber MI; Rodriguez FC; Choi JM; Tellides G; Pober JS; Kawikova I; Bothwell AL
    Circulation; 2011 Jul; 124(2):196-205. PubMed ID: 21690493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells.
    Hagen KA; Moses CT; Drasler EF; Podetz-Pedersen KM; Jameson SC; Khoruts A
    J Immunol; 2004 Sep; 173(6):3909-15. PubMed ID: 15356139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity.
    Yan K; Cao Q; Reilly CM; Young NL; Garcia BA; Mishra N
    J Biol Chem; 2011 Aug; 286(33):28833-28843. PubMed ID: 21708950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
    Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
    J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia.
    Bourgeois C; Stockinger B
    J Immunol; 2006 Oct; 177(7):4558-66. PubMed ID: 16982893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
    Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
    Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
    Zhang MA; Rego D; Moshkova M; Kebir H; Chruscinski A; Nguyen H; Akkermann R; Stanczyk FZ; Prat A; Steinman L; Dunn SE
    Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9505-10. PubMed ID: 22647601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
    Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
    J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4
    Knop L; Frommer C; Stoycheva D; Deiser K; Kalinke U; Blankenstein T; Kammertoens T; Dunay IR; Schüler T
    Front Immunol; 2019; 10():140. PubMed ID: 30792713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell-specific-peroxisome proliferator-activated receptor γ deficiency augments contact hypersensitivity with impaired regulatory B cells.
    Su J; Wang K; Zhou X; Wang Y; Xu J; Tao L; Zeng X; Chen N; Bai X; Li X
    Immunology; 2019 Mar; 156(3):282-296. PubMed ID: 30471095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.
    Efimova O; Szankasi P; Kelley TW
    PLoS One; 2011 Jan; 6(1):e16013. PubMed ID: 21253614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma promotes lymphocyte survival through its actions on cellular metabolic activities.
    Jo SH; Yang C; Miao Q; Marzec M; Wasik MA; Lu P; Wang YL
    J Immunol; 2006 Sep; 177(6):3737-45. PubMed ID: 16951334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
    Grinberg-Bleyer Y; Saadoun D; Baeyens A; Billiard F; Goldstein JD; Grégoire S; Martin GH; Elhage R; Derian N; Carpentier W; Marodon G; Klatzmann D; Piaggio E; Salomon BL
    J Clin Invest; 2010 Dec; 120(12):4558-68. PubMed ID: 21099113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
    Schulte R; Wohlleber D; Unrau L; Geers B; Metzger C; Erhardt A; Tiegs G; van Rooijen N; Heukamp LC; Klotz L; Knolle PA; Diehl L
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different competitive capacities of Stat4- and Stat6-deficient CD4+ T cells during lymphophenia-driven proliferation.
    Sanchez-Guajardo V; Borghans JA; Marquez ME; Garcia S; Freitas AA
    J Immunol; 2005 Feb; 174(3):1178-87. PubMed ID: 15661871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.